Back to search

Poland· PL-100108527

Kabiven Peripheral

A lösungen zur parenteralen ernährung, kombinationen product containing preparat złożony, registered in Poland by Fresenius Kabi AB. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedKabiven PeripheralATCB05BA10REGISTER NO.PL-100108527PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Preparat złożony
Manufacturer
Fresenius Kabi AB
Country
Poland (PL)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909990929016
  • gtin
    05909990929023
  • gtin
    05909990929030
  • gtin
    05909990053643
  • gtin
    05909990053629
  • gtin
    05909990053636

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/12d89a15-ef50-4a24-a44b-e158c9e99a6c
GET /v1/drugs/12d89a15-ef50-4a24-a44b-e158c9e99a6c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsja do infuzji",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909990929016 ¦ Lz ¦ Skasowane ¦ 19355\n1 poj. 1440 ml (885 ml + 300 ml + 255 ml)\n05909990929023 ¦ Lz ¦ Skasowane ¦ 19356\n1 poj. 1920 ml (1180 ml + 400 ml + 340 ml)\n05909990929030 ¦ Lz ¦ Skasowane ¦ 19357\n1 poj. 2400 ml (1475 ml + 500 ml + 425 ml)\n05909990053643 ¦ Lz ¦ 25987\n1 poj. 2400 ml (1475 ml + 500 ml + 425 ml)\n05909990053629 ¦ Lz ¦ 36295\n1 poj. 1440 ml (885 ml + 300 ml + 255 ml)\n05909990053636 ¦ Lz ¦ 36296\n1 poj. 1920 ml ( 1180 ml + 400 ml + 340 ml)",
  "substance": "Histidinum 3.4 g + Soiae oleum raffinatum 85 g + Glucosum monohydricum 178 g + Alaninum 8 g + Arginina 5.6 g + Acidum asparaginicum 1.7 g + Glutamic acid 2.8 g + Glicyna 4 g + izoleucyna 2.8 g + Leucine 4 g + Lizyny chlorowodorek 5.6 g + Methioninum 2.8 g + Phenylalaninum 4 g + prolina 3.4 g + Serine 2.2 g + Treoninum 2.8 g + Tryptophanum 0.95 g + Tyrosine 0.12 g + Valinum 3.6 g + Calcii chloridum dihydricum 0.49 g + Magnezu siarczan siedmiowodny 1.6 g + Kalii chloridum 3 g + Sodu octan trójwodny 4.1 g",
  "common_name": "Preparat złożony",
  "pl_product_id": "100108527",
  "pozwolenie_nr": "09290",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.